10/3
06:17 am
aim
Rating for AIM
Low
Report
Rating for AIM
9/10
07:54 am
aim
AIM ImmunoTech (NYSE:AIM) was upgraded by analysts at Maxim Group to a "strong-buy" rating.
Medium
Report
AIM ImmunoTech (NYSE:AIM) was upgraded by analysts at Maxim Group to a "strong-buy" rating.